Carcinogenesis: Balance between apoptosis and survival pathways

Apoptosis, Cell Signaling, and Human Diseases

Volumn 1, Issue , 2007, Pages 97-118

  Tang, Dean G ^a   Kehrer, James P ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; FOXO3a; lipocalin; NF B; reactive oxygen species (ROS); stress; survival

Indexed keywords

EID: 77951756994     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-200-7_4     Document Type: Chapter

References (184)

1. Adams JM. Ways of dying: multiple pathways to apoptosis. Gene Dev 2003;17:2481-2495.
2. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004;116:205-219.
3. Waxman DJ, Schwartz PS. Harnessing apoptosis for improved anticancer gene therapy. Cancer Res 2003;63:8563-8572.
4. Sprick MR, Walczak H. The interplay between the Bcl-2 family and death receptor-mediated apoptosis. Biochim Biophys Acta 2004;1644:125-132.
5. Wang J, Lenardo MJ. Role of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J Cell Sci 2000;113:753-757.
6. Salveson GS. Caspases and apoptosis. Essays Biochem 2002;38:9-19.
7. Fulda S, Debatin KM. Signaling through death receptors in cancer therapy. Curr Opin Pharmacol 2004;4:327-332.
8. Chang DW, Ditsworth D, Liu H, Srinivasula SM, Alnemri ES, Yang X. Oligomerization is a general mechanism for the activation of initiator and inflammatory procaspases. J Biol Chem 2003;278:16, 466-16, 469.
9. Chen M, Oroszo A, Spencer DM, Wang J. Activation of initiator caspases through a stable dimeric intermediate. J Biol Chem 2002;277:50, 761-50, 767.
10. Donepudi M, Sweeney AM, Briand C, Grutter MG Insights into the regulatory mechanism for caspase-8 activation. Mol Cell 2003;11:543-549.
11. Boatright KM, Renatus M, Scott FL, et al. A unified model for apical caspase activation. Mol Cell 2003;11:529-541.
12. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev 2001;15:2922-2933.
13. Shiozaki EN, Chai J, Rigotti DJ, et al. Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 2003;11:519-527.
14. Joazeiro CA, Weissman AM. RING finger proteins: Mediators of ubiquitin ligase activity. Cell 2000;102:549-552.
15. Verhagen AM, Ekert PG, Pakusch M, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to an antagonizing IAP proteins. Cell 2000;102:43-53.
16. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000;102: 33-42.
17. Verhagen AM, Silke J, Ekert PG, et al. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem 2002;277:445-454.
18. Susin SA, Lorenzo HK, Zamzani N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441-446.
19. Li LY, Luo X, Wang X Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001;412:95-99.
20. Zamzami N, Marchetti P, Castedo M, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995;182:367-377.
21. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999;13:1899-1911.
22. Degterev A, Boyce M, Yuan J. The channel of death. J Cell Biol 2001;155:695-697.
23. Scorrano L, Korsmeyer SJ. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochim Biophys Res Comm 2003;304:437-444.
24. Eposti MD, Dive C. Mitochondrial membrane permeabilization by Bax/Bak. Biochim Biophys Res Comm 2003;304:455-461.
25. Curtin JF, Donovan M, Cotter TG. Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 2002;265:49-72.
26. Li PF, Dietz R, von Harsdorf R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J 1999;18:6027-6036.
27. Gottlieb E, Vander Heiden MG, Thompson CB. Bcl-x(L) prevents initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol 2000;20:5680-5689.
28. Behrend L, Henderson G, Zwacka RM. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 2003;31:1441-1444.
29. Gottlieb RA. Mitochondria: Execution central. FEBS Lett 2000;482:6-12.
30. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998;94:491-501.
31. Sattler M, Liang H, Nettesheim D, et al. Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis. Science 1997;275:983-986.
32. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
33. Matsuyama S, Reed JC. Mitochondria dependent apoptosis and cellular pH damage. Cell Death Diff 2000;7:1155-1165.
34. Yu SP, Canzoniero LM, Choi DW. Ion homeostasis and apoptosis. Curr Opin Cell Biol 2001;13:405-411.
35. Hsu YT, Youle RJ. Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 1997;272:13, 829-13, 834.
36. Wilson-Annan J, O'Reilly LA, Crawford SA, et al. Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity. J Cell Biol 2003; 162:877-888.
37. Nakai M, Takeda A, Cleary ML, Endo T. The Bcl-2 protein is inserted into the outer membrane but not into the inner membrane of rat liver mitochondria in vitro. Biochem Biophys Res Comm 1993;196:233-239.
38. Distelhorst CW, Shore GC. Bcl-2 and calcium: controversy beneath the surface. Oncogene 2004;23:2875-2880.
39. Massaad CA, Portier BP, Taglialatela G. Inhibition of transcription factor activity by nuclear compartment-associated Bcl-2. J Biol Chem 2004;279:54, 470-54, 478.
40. Kitada S, Andersen J, Akar S, et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 1998;91:3379-3389.
41. McDonnell TJ, Beham A, Sarkiss M, Andersen MM, Lo P. Importance of Bcl-2 family in cell death regulation. Experentia 1996;52:1008-1017.
42. Robertson LE, Plunkett W, McConnell K, Keating MJ, McDonnell TJ. Expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia 1996;10:456-459.
43. Pratesi G, Perego P, Zunino F. Role of Bcl-2 and its post-transcriptional modification in response to antitumor therapy. Biochem Pharmacol 2001;61:381-386.
44. Haldar S, Jena N, Croce CM. Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 1995;92:4507-4511.
45. Haldar S, Chintapalli J, Croce CM. Taxol induces Bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 1996;56:1253-1255.
46. Ito T, Deng X, Carr B, May WS. Bcl-2 phosphorylation required for its anti-apoptotic function. J Biol Chem 1997;272:11, 671-11, 673.
47. Chang BS, Minn AJ, Muchmore SW, Fesik SW, Thompson CB. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J 1997;16:968-977.
48. Kirsch DG, Doseff A, Chau BN, et al. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 1999;274:21, 155-21, 161.
49. Karin M, Lin A. NF-KB at the crossroads of life and death. Nat Immunol 2002;3:221-227.
50. Lin A, Karin M. NF-KB in cancer: a marked target. Sem Cancer Biol 2003;13:107-114.
51. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. NF-KB signals induce the expression of c-FLIP Mol Cell Biol 2001;21:5299-5305.
52. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998;17:2215-2223.
53. Baldwin AS, Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649-683.
54. Levkau B, Scatena M, Giachelli CM, Ross R, Raines EW. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop. Nat Cell Biol 1999;1:227-233.
55. Reuther JY, Baldwin AS, Jr. Apoptosis promotes a caspase-induced amino-terminal truncation of IkappaBalpha that functions as a stable inhibitor of NF-kappaB. J Biol Chem 1999;274:20, 664-20, 670.
56. Tang G, Yang J, Minemoto Y, Lin A. Blocking caspase-3-mediated proteolysis of IKKbeta suppresses TNF-alpha-induced apoptosis. Mol Cell 2001;8:1005-1016.
57. Hong SY, Yoon WH, Park JH, Kang SG, Ahn JH, Lee TH. Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha-, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J Biol Chem 2000;275:18, 022-18, 028.
58. Arch RH, Gedrich RW, Thompson CB. Translocation of TRAF proteins regulates apoptotic threshold of cells. Biochem Biophys Res Commun 2000;272:936-945.
59. Staal SP. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci USA 1987;84:5034-5037.
60. Nicholson KM, Anderson NG. The protein kinase B/Akt signaling pathway in human malignancy. Cell Signal 2002;14:381-395.
61. Brazil DP, Yang ZZ, Hemmings BA. Advances in protein kinase B signaling: AKTion on multiple fronts. Trends Biochem Sci 2004;29:233-242.
62. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 1996;15: 6541-6551.
63. Scheid MP, Woodgett JR. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett 2003;546;108-112.
64. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 2003;22:8983-8998.
65. Mora A, Komander D, van Aalten DMF, Alessi DR. PDK1, the master regulator of AGC kinase signal transduction. Sem Cell & Develop Biol 2004;15:161-170.
66. Kobayashi T, Cohen P. Activation of serum-and glucocorticoids-regulated protein kinase by agonists that activate phosphatidyl 3-kinase is mediated by 3-phosphoinositide-depend-ent protein kinase-1 (PDK1) and PDK2. Biochem J 1999:339;319-328.
67. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME. Protein kinase SGK mediates survival signals by phosphorylating the Forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 2001;21:952-965.
68. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002;2:489-501.
69. Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 2003;3:942-943.
70. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96:857-868.
71. Cardone MH, Roy N, Stennicke HR, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998;282:1318-1321.
72. Sordet O, Khan Q, Kohn KW, Pommier Y. Apoptosis induced by topoisomerase inhibitors. Curr Med Chem Anticancer Agents 2003;3:271-290.
73. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999;401:82-85.
74. Romashkova JA, Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999;401:86-90.
75. Chang F, Steelman LS, Shelton JG, et al. Regulation of cell cycle progression and apoptosis by the Ras/Raf/ERK pathway. Int J Oncol 2003;22:469-480.
76. Lowenstein EJ, Daly RJ, Batzer AG, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 1992;70:431-442.
77. Chardin P, Camonis JH, Gale NW, et al. Human SOS1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 1993;260:1338-1343.
78. Xia Z, Dickens M, Raingeaurd J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-1331.
79. Harada H, Quearry B, Ruiz-Vela A, Korsmeyer SJ. Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proc Natl Acad Sci USA 2004;101:15, 313-15, 317.
80. Marani M, Hancock D, Lopes R, Tenev T, Downward J, Lemoine NR. Role of Bim in the survival pathway induced by Raf in epithelial cells. Oncogene 2004;23:2431-2441.
81. Wang P, Gilmore AP, Streuli CH. Bim is an apoptosis sensor that responds to loss of survival signals delivered by epidermal growth factor but not those provided by integrins. J Biol Chem 2004;279:41, 280-41, 285.
82. Chalmers CJ, Balmanno K, Hadfield K, Ley R, Cook SJ. Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1. Biochem J 2003;375:99-109.
83. Reginato MJ, Mills KR, Paulus JK, et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol 2003;5:733-740.
84. Molton SA, Todd DE, Cook SJ. Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3'-kinase (PI3K) pathway is inhibited. Oncogene 2003;22:4690-4701.
85. Ley R, Balmanno K, Hadfield K, Weston C, Cook SJ. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J Biol Chem 2003;278:18, 811-18, 816.
86. Weston CR, Balmanno K, Chalmers C, et al. Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways. Oncogene 2003;22: 1281-1293.
87. LeGrand, EK. An adaptationist view of apoposis. Quart Rev Biol 1997;72:135-147.
88. Joshi B, Li L, Taffe BG, et al. Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain. Cancer Res 1999;59:4343-4355.
89. Chandra D, Liu JW, Tang DG. Early mitochondrial activation and cytochrome c up-regulation during apoptosis. J Biol Chem 2002;277:50, 842-50, 854.
90. Martin AG, Fearnhead HO. Apocytochrome c blocks caspase-9 activation and Bax-induced apoptosis. J Biol Chem 2002;277:50, 834-50, 841.
91. 2 in mitochondria. J Biol Chem 2003;278:2356-2360.
92. Martin AG, Nguyen J, Wells JA, Fearnhead HO. Apo cytochrome c inhibits caspases by preventing apoptosome formation. Biochim Biophys Res Comm 2004;319:944-950.
93. Liu J-W, Chandra D, Rudd MD, et al. Induction of pro-survival molecules by apoptotic stimuli: Involvement of FOXO3a and ROS. Oncogene 2005;24:2020-2031.
94. Dong Z, Wang J. Hypoxia selection of death-resistant cells: A role for Bcl-xL. J Biol Chem 2004;279:9215-9221.
95. Nijhawan D, Fang M, Traer E, et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003;17:1475-1486.
96. Sherrill KW, Byrd MP, Van Eden ME, Lloyd RE. BCL-2 translation is mediated via internal ribosome entry during cell stress. J Biol Chem 2004;279:29, 066-29, 074.
97. Bachelor MA, Bowden TG. Ultraviolet A-induced Modulation of Bcl-XL by p38 MAPK in Human Keratinocytes. Post-transcriptional regulation through the 3'-untranslated region. J Biol Chem 2004;279:42, 658-42, 668.
98. Kinnula VL, Crapo JD. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 2003;167:1600-1619.
99. Mikkelsen RB, Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 2003;22:5734-5754.
100. Chen J-G, Yang C-PH, Cammer M, Horwitz SB. Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res 2003;63:7891-7899.
101. Takayama S, Reed JC, Homma S. Heat-shock proteins as regulators of apoptosis. Oncogene 2003;22:9041-9047.
102. Parcellier A, Schmitt E, Gurbuxani S, et al. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Mol Cell Biol 2003;23:5790-5802.
103. Garrido C, Solary E. A role of HSPs in apoptosis through "protein triage"? Cell Death Differ 2003;10:619-620.
104. Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates transmembrane potential. J Biol Chem 2004;279:25, 689-25, 695.
105. Zhang L, Pelech S, Uitto V-J. Bacterial Gro-EL heat shock protein 60 protects epithelial cells from stress-induced death through activation of ERK and inhibition of caspase 3. Exp Cell Res 2004;292:231-240.
106. Green DR, Evan GI. A matter of life and death. Cancer Cell 2001;1:19-30.
107. Shibue T, Takeda K, Oda E, et al. Integral role of Noxa in p53-mediated apoptotic response. Genes & Dev 2003;17:2233-2238.
108. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA 2003;100:1931-1936.
109. Mahyar-Roemer M, Roemer K. p21 Waf/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 2001;20:3387-3398.
110. ARF and p53 levels and alteration of the Bax/Bcl-2 ratio. J Biol Chem 2002;277:37, 949-37, 954.
111. Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis. Oncogene 2004;23 4862-4872.
112. Tong Z, Wu X, Kehrer JP Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886. Biochem J 2003;372:203-210.
113. Flower DR. The lipocalin protein family: structure and function. Biochem J 1996;318:1-14.
114. Flower DR. Beyond the superfamily: the lipocalin receptors. Biochim Biophys Acta 2000;1482:327-336.
115. Elangovan N, Lee Y-C, Tzeng W-F, Chu S-T Delivery of ferric ion to mouse spermatozoa is mediated by lipocalin internalization. Biochem Biophys Res Commun 2004;319: 1096-1104.
116. Flower DR. The lipocalin protein family: a role in cell regulation. FEBS Lett 1994;354: 7-11.
117. Bratt T. Lipocalins and cancer. Biochim Biophys Acta 2000;1482:318-326.
118. Hraba-Renevey S, Türler H, Kress M, Salomon C, Weil R. SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene 1989;4:601-608.
119. Kjeldsen L, Cowland JB. Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 2000;1482:272-283.
120. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993; 268:10, 425-10, 432.
121. Yang J, Goetz D, Li J-Y, et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002;10:1045-1056.
122. Ryon J, Bendickson L, Nielsen-Hamilton M. High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem J 2002;367:271-277.
123. Devireddy LR, Teodoro JG, Richard FA, Green MR. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 2001;293:829-834.
124. Di Marco E, Sessarego N, Zerega B, Cancedda R, Cancedda FD. Inhibition of cell proliferation and induction of apoptosis by ExFABP targeting. J Cell Physiol 2003;196:464-473.
125. Lu PD, Jousse C, Marciniak SJ, et al. Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2. EMBO J 2004;23:169-179.
126. Donze O, Deng J, Curran J, Sladek R, Picard D, Sonerberg N. The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J 2004;23: 564-571.
127. Fujioka S, Schmidt C, Sclabas GM, et al. Stabilization of p53 is a novel mechanism for proapoptotic function of NF-KB. J Biol Chem 2004;279:27, 549-27, 559.
128. Campbell KJ, Rocha S, Perkins ND. Active repression of antiapoptotic gene expression by RelA(p65) NF-KB. Mol Cell 2004;13:853-865.
129. Zamora M, Merono C, Vinas O, Mampel T. Recruitment of NF-KB into mitochondria is involved in adenine nucleotide translocase 1 (ANT1)-induced apoptosis. J Biol Chem 2004;279:38, 415-38, 423.
130. Tergaonkar V, Pando M, Vafa O, Wahl G, Verma I. p53 stabilization is decreased upon NF-KB activation: a role for NFKB in acquisition of resistance to chemotherapy. Cancer Cell 2002; 1:493-503.
131. Jang J-H, Surh Y-J. Bcl-2 attenuation of oxidative cell death is associated with up-regulation of g-glutamylcysteine ligase via constitutive NF-KB activation. J Biol Chem 2004;279: 38, 779-38, 786.
132. Mabuchi S, Ohmichi M, Nishio Y, et al. Inhibition of NFKB increases the efficacy of cis-platin in in vitro and in vivo ovarian cancer models. J Biol Chem 2004;279:23, 477-23, 485.
133. Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature 2004;431:405-406.
134. Pikarsky E, Porat RM, Stein I, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-466.
135. Clevers H. At the crossroads of inflammation and cancer. Cell 2004;118:671-674.
136. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NF-kappaB in cancer cells converts inflammation-induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 2004;6:297-305.
137. Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004;6:203-208.
138. Legembre P, Schickel R, Barnhart BC, Peter ME. Identification of SNF1/AMP kinase-related kinase as an NF-B-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness. J Biol Chem 2004;279:46, 742-46, 747.
139. Pham CG, Bubici C, Zazzeroni1 F, et al. Ferritin heavy chain upregulation by NF-KB inhibits TNF-induced apoptosis by suppressing reactive oxygen species. Cell 2004;119:529-542.
140. Algeciras-Schmnich A, Pietras EM, Barnhart BC, et al. Two CD95 tumor classes with different sensitivities to antitumor drugs. Proc Natl Acad Sci USA 2003;100:11, 445-11, 450.
141. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003;114:181-190.
142. Ehrhardt H, Fulda S, Schmid I, Hiscott J, Debatin K-M, Jeremias I. TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-KB. Oncogene 2003;22:3842-3852.
143. Huerta-Yepez S, Vega M, Jazirehi A, et al. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-KB and inhibition of Bcl-xL expression. Oncogene 2004;23:4993-5003.
144. Kreuz S, Siegmund D, Rumpf J-J, et al. NF-KB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J Cell Biol 2004;166:369-380.
145. Imamura R, Konaka K, Matsumoto N, et al. Fas ligand induces cell-autonomous NF-KB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-a. J Biol Chem 2004;279:46, 415-46, 423.
146. Barnhart BC, Legenbre P, Pietras E, Bubici C, Franzoso G, Peter ME. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J 2004;23:3175-3185.
147. Danial NN, Gramm CF, Scorrano L, et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 2003;424:952-956.
148. Seo SY, Chen Y, Ivanovska I, et al. BAD is a pro-survival factor prior to activation of its proapoptotic function. J Biol Chem 2004;279:42, 240-42, 249.
149. Nakajima K, Hirose H, Taniguchi M, et al. Involvement of BNIP1 in apoptosis and endoplasmic reticulum membrane fusion. EMBO J 2004;23:3216-3226.
150. Jones JM, Datta P, Srinivasula SM, et al. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 2003;425:721-727.
151. Cheng EH-Y, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 2003;301:513-517.
152. Fannjiang Y, Kim CH, Huganir RL, et al. BAK alters neuronal excitability and can switch from anti-to pro-death function during postnatal development. Dev Cell 2003;4:575-585.
153. Yang L, Cao Z, Yan H, Wood WC. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 2003;63:6815-6824.
154. Newton K, Strasser A. Caspases signal not only apoptosis but also antigen-induced activation in cells of the immune system. Genes Dev 2003;17:819-825.
155. Birkenkamp KU, Coffer PJ. FOXO transcription factors as regulators of immune homeostasis: Molecules to die for? J Immunol 2003;171:1623-1629.
156. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004;117:421-426.
157. Burgering BMT, Kops GJPL. Cell cycle and death control: long live Forkheads. Trends Biochem Sci 2002;27:352-360.
158. Rokudal S, Fujita N, Kitahara O, Nakamura Y, Tsuruo T. Involvement of FKHR-dependent TRADD expression in chemotherapy drug-induced apoptosis. Mol Cell Biol 2002;22: 8695-8708.
159. Burgering BMT, Medema RH. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukocyte Biol 2003;73:689-701.
160. El-Deiry W. The role of p53 in chemosensitivity and radisensitivity. Oncogene 2003;22: 7486-7495.
161. Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene 2003;22:9030-9040.
162. Lo PK, Huang SZ, Chen HC, Wang FF. The prosurvival activity of p53 protects cells from UV-induced apoptosis by inhibiting c-Jun NH2-terminal kinase activity and mitochondrial death signaling. Cancer Res 2004;64:8736-8745.
163. Chau BN, Wang YJ. Coordinated regulation of life and death by RB. Nat Rev Cancer 2003;3:130-138.
164. Bell LA, Ryan KM. Life and death decisions by E2F-1. Cell Death and Differ 2003;10: 1-6.
165. Dhakshinamoorthy S, Porter AG. Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells. J Biol Chem 2004;279:20, 096-20, 107.
166. Cullinan SB, Diehl JA. ERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J Biol Chem 2004;279:20, 108-20, 117.
167. You H, Jang Y, You-Ten AI, et al. p53-dependent inhibition of FKHRL1 in response to DNA damage through protein kinase SGK1. Proc Natl Acad Sci USA 2004;101:14, 057-14, 062.
168. Hu MC, Lee DF, Xia W, et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004;117:225-237.
169. Lin L, Hron JD, Peng SL. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 2004;21:203-213.
170. Huang H-L, Fang L-W, Lu S-P, Chou C-K, Luh T-Y, Lai M-Z. DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Oncogene 2003;22:8168-8177.
171. Katoh I, Tomimori Y, Ikawa Y, Kurata S. Dimerization and processing of procaspase-9 by redox stress in mitochondria. J Biol Chem 2004;279:15, 515-15, 523.
172. Sattler M, Winkler T, Verma S, et al. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 1999;93:2928-2935.
173. Sundaresan M, Yu ZX, Ferrons VJ, Irani K, Finkel T. Requirement for generation of HO2 for platelet-derived growth factor signal transduction. Science 1995;270:296-299.
174. Vaquero EC, Edderkaoui M, Pandol SJ, Gukovsky I, Gukovskaya AS. Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 2004;279:34, 643-34, 654.
175. 0-M checkpoint in response to oxidative stress. J Biol Chem 2002;277:26, 729-26, 732.
176. Kops GJPL, Dansen TB, Polderman PE, et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002;419:316-321.
177. Nemoto S, Finkel T. Redox regulation of forkhead proteins through a/?6&y/ic-dependent signaling pathway. Science 2002;295:2450-2452.
178. Brunet A, Sweeney LB, Sturgill JF, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004;303:2011-2015.
179. Essers MA, Weijzen S, de Vries-Smits AM, et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 2004;23:4802-4812.
180. Yin L, Huang L, Kufe D. MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress. J Biol Chem 2004;279:45, 721-45, 727.
181. Nakata S, Matsumura I, Tanaka H, et al. NFKB family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species. J Biol Chem. 2004; 279:55, 578-55, 586.
182. Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol 2003;23:8576-8585.
183. McCormick F Survival pathways meet their ends. Nature 2004;428:267-269.
184. Wendel H-G, de Stanchina E, Fridman JS, et al. Survival signaling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004;428:332-337.